CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home

Top 10 BioTech Startups - 2021

In the simplest sense, medical biotechnology revolves around the concept of using living cells and cell materials to bring innovative pharmaceutical and diagnostic products to the table for the prevention of diseases. The last few years have witnessed several advancements in biotechnology that have been saviors for human civilization. One example will be the development of vaccines to fight the Ebola virus outbreak in West Africa. Biotechnology researchers have also found novel treatment methods for cancer as well in the forms of immuno-oncology and gene therapy. They are on a mission to replace the time-consuming and painful chemotherapy and other traditional treatment options (that often fail to save patients) with more effective treatment methods. That’s not all! Biotechnology is also reshaping the paradigm of other chronic inflammatory-based diseases, including ischemic heart disease, stroke, diabetes mellitus, chronic kidney disease, non-alcoholic fatty liver disease (NAFLD), and autoimmune and neurodegenerative conditions.

Such advancements in biotechnology would not have been possible without the emergence of some innovative start-ups. Led by industry veterans, expert physicians, and scholars, these entities are constantly striving to change the status quo—and this is not limited to discovering unique treatment methods. To elucidate, companies need to rely on clinical research organizations (CROs) to bring a new drug to the market. But in many cases, CROs fail to assess the risk to budget. This lack of funding ultimately leads to drug trial failure. To address this quandary, many biotech start-ups are helping drug manufacturers take a more data-driven approach to understand the efficiency of their outsourced partners or CROs.

Needless to say, such agile start-ups will drive biotech research to new heights in the coming years. Life Science Review has compiled a list of leading biotech start-ups to help readers have a better understanding of this field.

We present to you Life Science Review’s “Top 10 BioTech Startups - 2021"

TOP VENDORS
Top 10 BioTech Startups - 2021

Nominate a Company

Our subscribers nominate the companies with whom they have collaborated and gotten results. If you think there is a company that deserves to be on our upcoming prestigious annual list of Top 10 BioTech Startups , please write to us about them and the reasons you think they need to be on the list

* 

Thank You!

checkmark

Your nomination request for upcoming annual list of "Top 10 BioTech Startups " has been Successfully Sent . We will be in touch with you shortly.

Data not inserted

    Top BioTech Startups

  • Berkshire Sterile Manufacturing

    Berkshire Sterile Manufacturing

    VIEW PROFILE

    Berkshire Sterile Manufacturing (BSM) provides the safest sterile drug products for clinical use and small-scale requirements through the use of modern technology, 100% isolator-based filling lines, and skilled staff. BSM offers sterile filling of syringes, vials (RTU and bulk), cartridges, custom containers, and lyophilized products. BSM also provides onsite analytical support and stability programs. BSM is a customer-focused, quality-driven contract manufacturer of sterile injectables

    Our philosophy is to offer quality, and innovation to customers, utilizing new technologies to improve the sterility assurance and quality of the products while ensuring regulatory compliance

    —Shawn Kinney, CEO

    Berkshire Sterile Manufacturing

    100-500

    Visit vendor website

    Management
    Shawn Kinney, CEO

    BioTech Startups by Berkshire Sterile Manufacturing :

    • Contract Manufacturing
    • Process Development and formulation scale up
    • Analytical method development
    • Lyophilization
    • Terminal Sterilization
    • Analytical and Microbiological Services
    • Biologics
    • Prefilled Syringes
    • Parenteral Developmen
    • and Biotechnology

  • bioXcellerator

    bioXcellerator

    VIEW PROFILE

    A global leader in stem cell therapy and research, dedicated to alleviating pain and suffering from autoimmune and degenerative diseases and help people enjoy longer and healthier lives. Based on innovations at the cutting edge of life sciences and regenerative medicine that was impossible to envision even a few years ago, BioXcellerator helps patients who suffer from a wide range of diseases, disorders, and injuries. The company is also focused on treating chronic traumatic encephalopathy (CTE) because many veterans and athletes who are diagnosed with post-traumatic stress disorder (PTSD) may actually be suffering from a physical brain injury that stem cell therapy can help treat

    bioXcellerator

    Less than 100

    Visit vendor website

    Management
    Eric Stoffers, Founder and CEO

    BioTech Startups by bioXcellerator :

    • bioscience
    • stem cell research
    • stem cell therapy
    • wellness centers
    • health care
    • rejuvenation treatment
    • alternative medicine
    • golden cells
    • regenerative therapy
    • stem cell research
    • and medical tourism

  • ClearLight Biotechnologies

    ClearLight Biotechnologies

    VIEW PROFILE

    ClearLight Biotechnologies is a California-based company that empowers researchers to See More Biology™within the tissue microenvironment. The company provides CLARITY Tissue Clearing, 3D Immunohistochemistry (IHC), and Tru3D® Image Analysis services to pharmaceutical, biotechnology, and academic researchers. ClearLight works with larger undisturbed tissue volumes as compared to 2D thin section tissue slices.With the company’s tehnology researchers gain greater insights into the tissue’s subcellular structure when the third dimension is added. This technology has the potential to reduce the cost and failure rates of potential drug candidates during the costly drug development process

    We create a hybrid tissue scaffold using CLARITY that allows us to see beyond the surface of the tissues and see deeper for spatial analysis

    —Sharla White, PhD, Vice President of Research and Development

    ClearLight Biotechnologies

    Less than 100

    Visit vendor website

    Management
    Sharla White, PhD, Vice President of Research and Development

    BioTech Startups by ClearLight Biotechnologies :

    • lab services
    • 3d image analysis
    • immunooncology
    • CLARITY
    • tissue clearing
    • FFPE Tissue
    • drug discovery
    • biology
    • neuroscience
    • frozen tissue
    • optical imaging
    • oncology
    • immunology

  • Eikonoklastes Therapeutics

    Eikonoklastes Therapeutics

    VIEW PROFILE

    Eikonoklastes, a preclinical stage biopharmaceutical company, brings a novel approach to treating multiple solid tumors, including triple-negative breast cancer, ovarian cancer, and malignant melanoma. By developing novel immunotherapies that target tissue factors, a cell surface receptor prevalent in certain pathological cells, the company is making a breakthrough in cancer treatment. Eikonoklastes immunoconjugate technology was discovered by its scientific founder, Dr. Zhiwei Hu, who licensed it from the Ohio State University. He had realized the ubiquitous nature of tissue factor while working at Yale many years earlier. In his research, he identified tissue factor as a common biomarker and therapeutic target on various cancer cells and various types of solid tumors

    Currently, we are focusing on the treatment of triple-negative breast cancer, ovarian cancer, and malignant melanoma, mainly because of its lowest survival rates

    —Bruce Halpryn, CEO

    Eikonoklastes Therapeutics

    Less than 100

    Visit vendor website

    Management
    Bruce Halpryn, CEO

    BioTech Startups by Eikonoklastes Therapeutics :

    • next-generation tissue factor (TF) immunotherapies
    • developing a state of the art immune conjugate technology targeting tissue factor

  • Keystone

    Keystone

    VIEW PROFILE

    Keystone Bio is a clinical-stage biopharmaceutical company. It is pioneering novel disease-modifying, precision, anti-bacterial bio- therapeutics/preventive along with companion diagnostics to target an important and largely unaddressed chronic bacterial infection and driver of systemic chronic inflammation that significantly contribute to multiple inflammatory disease states such as heart disease and dementia/Alzheimer’s disease. The company’s lead bio-therapeutic, KB-001 precision monoclonal antibody, disrupts the later stages of the major protein surface processing machinery. It also prevents the maturation of the unique subunit toxin —needed for its survival and the creation of its secreted outer membranes vesicles (OMVs), resulting in the bacteria shutting down it metabolic functions

    Chronic inflammatory diseases have turned out to be a worldwide epidemic. KB-001 has equipped us with the ability to better help these patients and offer them a better life

    Dr. Daniel Sindelar, DMD CEO and Dr. Peter Nara, D.V.M., Ph.D., FAAAS,CSO/V.P BD

    Keystone

    Less than 100

    Visit vendor website

    Management
    Dr. Daniel Sindelar, DMD CEO and Dr. Peter Nara, D.V.M., Ph.D., FAAAS,CSO/V.P BD
    Dr. Garth Ehrlich, Ph.D., FAAAS/SAB, Dr. Marc Penn MD, PhD CMO

    BioTech Startups by Keystone :

    • biotechnology
    • anti-bacterial therapeutics
    • chronic inflammation
    • diagnostics
    • anti-inflammation
    • microbial pathogens
    • cardiovascular disease
    • dementia
    • Alzheimer’s
    • atherosclerosis
    • and monoclonal antibody

  • LevitasBio

    LevitasBio

    VIEW PROFILE

    Levitas, Inc. is redefining cellular processing with its next generation levitation technology. LevitasBio’s disruptive technology overcomes cellular processing’s current technological shortcoming by providing a label-free, simple, and gentle method of isolating specific cell populations. Its flagship product, the LeviCell platform, enables studies and beneficial uses of previously inaccessible, high-value primary samples and sensitive cell types regardless of the starting cell number, viability, or sensitivity to processing

    We start right up from with native biological sample, and enable the researchers to process and analyze the sample in a way that doesn’t cause any damage, and doesn’t change the state of the sample itself

    —Paul Steinberg, Chief Commercial Officer and Martin Pieprzyk, CEO

    LevitasBio

    Less than 100

    Visit vendor website

    Management
    Paul Steinberg, Chief Commercial Officer and Martin Pieprzyk, CEO

    BioTech Startups by LevitasBio :

    • new and powerful method of cellular analysis
    • The LeviCell platform enables studies and beneficial uses of previously inaccessible
    • high-value primary samples and sensitive cell types
    • regardless of the starting cell number
    • viability
    • or sensitivity to processing

  • Nanotein Technologies

    Nanotein Technologies

    VIEW PROFILE

    Nanotein Technologies offers protein-based solutions that allow biopharma companies to produce longer-lived and more clinically effective CAR-T cells in a larger quantity, and more quickly. Its tunable and flexible platform technology accelerates CAR-T expansion and increases the number of cells produced per treatment. By providing more control over the types of T-cell subsets that are produced in an expansion, this platform technology allows manufacturers to shift therapeutic profiles, enhancing the longevity and effectiveness of the final cell therapy product. Its novel cell activation and expansion reagent dramatically accelerates the development process and enables manufacturers to grow T-cell cultures with new cell population profiles in unusually large amounts

    Our plug-and-play platform technology enables us to manipulate the cell surface of any cell with any antibody or combination of antibodies

    —Curtis Hodge, PhD, Co-Founder and CEO

    Nanotein Technologies

    Less than 100

    Visit vendor website

    Management
    Curtis Hodge, PhD, Co-Founder and CEO

    BioTech Startups by Nanotein Technologies :

    • protein-based solutions
    • The plug-and-play platform technology enables us to manipulate the cell surface of any cell with any antibody or combination of antibodies

  • R3 Stem Cell

    R3 Stem Cell

    VIEW PROFILE

    R3 Stem Cell has been at the forefront of performing regenerative therapies for the past decade. With over 16,000 regenerative therapies worldwide, they have never experienced a single significant adverse event. This is indeed a crowning achievement when compared to conventional treatment practices such as surgery and narcotic prescriptions. R3 Stem Cell’s therapies include PRP therapy, umbilical cord stem cell therapy, adipose cell therapy, and exosome therapy. The company is also among the most cost-effective regenerative therapy providers, thanks to its broad presence in the U.S. and abroad, spanning 45 centers

    R3 Stem Cell’s growth trajectory entails partnering with practices that are looking to leverage regenerative medicine

    David Greene, MD, MBA, Founder and CEO

    R3 Stem Cell

    Less than 100

    Visit vendor website

    Management
    David Greene, MD, MBA, Founder and CEO

    BioTech Startups by R3 Stem Cell :

    • Stem Cell Therapy
    • Medical Marketing
    • Healthcare Internet Marketing
    • Regenerative Medicine

  • Rakuten Medical

    Rakuten Medical

    VIEW PROFILE

    Rakuten Medical is a global biotechnology company developing precision, cell-targeting investigational therapies on its IlluminoxTM platform, which, in pre-clinical studies, has shown to lead to rapid and selective cell killing and tumor necrosis

    We at Rakuten Medical are focused on bringing an investigational treatment approach for our patients to provide them with one if the best options to fight cancer

    —Carlos Garcia, Chief Technology Officer

    Rakuten Medical

    100-500

    Visit vendor website

    Management
    Carlos Garcia, Chief Technology Officer

    BioTech Startups by Rakuten Medical :

    • Biotechnology
    • Cancer Therapeutics
    • Clinical Research

  • Seneca Therapeutics

    Seneca Therapeutics

    VIEW PROFILE

    Seneca Therapeutics is all set to move the needle in the cancer treatment space with its revolutionary cancer therapy. It is developing a pipeline of novel cancer agents utilizing Seneca Valley Virus-001 (SVV-001)—an oncolytic virus—that binds to the TEM8 (a single-pass cell surface protein predominantly expressed in tumor endothelium) receptor in solid tumors such as neuroendocrine tumors, breast cancer, and lung cancer. More importantly, SVV-001 converts cold tumors into hot tumors that enables T cells to recognize the tumor cells and destroy them

    It is not a human virus and no pre-treatment neutralizing antibody has been detected in humans

    —James Hussey, CEO

    Seneca Therapeutics

    Less than 100

    Visit vendor website

    Management
    James Hussey, CEO
    Paul Hallenbeck, President

    BioTech Startups by Seneca Therapeutics :

    • focuses on developing best-in-class oncolytic immunotherapeutics
    • derivatives as cancer therapeutics
    • cancer vaccine

  • Magazine

    Biotech Startups 2021

    Top Vendors

    Top 10 BioTech Startups - 2021

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-startups.lifesciencesreview.com/vendors/top-biotech-startups-2021.html